NCT05092646View on ClinicalTrials.gov

Evaluating Intra-articular Injection of Axolotl Ambient Compared to Saline in Subjects With Ankle Osteoarthritis

PHASE1/PHASE2TerminatedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

December 1, 2021

Primary Completion Date

November 10, 2023

Study Completion Date

November 10, 2023

Conditions
Ankle Osteoarthritis
Interventions
BIOLOGICAL

Axolotl Ambient

Axolotl Ambient is an allogeneic amniotic intra-articular injection therapy consisting of a growth factor and cytokine-rich fluid derived from human amnion cells.

DRUG

"Drug/Placebo: 0.9% Normal Saline"

"Drug/Placebo: 0.9% Normal Saline"

Trial Locations (3)

28207

OrthoCarolina Foot and Ankle Institute, Charlotte

71101

Orthopedic Specialists of Louisiana, Shreveport

83713

Injury Care Research, Boise

Sponsors

Lead Sponsor

Axolotl Biologix
All Listed Sponsors
lead

Axolotl Biologix

INDUSTRY

NCT05092646 - Evaluating Intra-articular Injection of Axolotl Ambient Compared to Saline in Subjects With Ankle Osteoarthritis | Biotech Hunter | Biotech Hunter